Tags

Type your tag names separated by a space and hit enter

Differences in symptoms between patients with benign and malignant ovarian neoplasms.
Am J Obstet Gynecol 2004; 190(5):1435-7AJ

Abstract

OBJECTIVE

The purpose of this study was to determine the symptoms that are experienced by patients who receive a diagnosis of early ovarian cancer and to compare those symptoms with the symptoms that are experienced by patients with late ovarian cancer, borderline ovarian cancer, and benign ovarian neoplasms.

STUDY DESIGN

This study used a retrospective case-control design. Cases of invasive and borderline ovarian cancer (n=147 patients) were compared with 76 patients with benign ovarian neoplasms.

RESULTS

Patients with early ovarian cancer were significantly more likely to have symptoms of mass effect (urinary frequency, constipation, palpable mass, pelvic pressure) compared with patients with benign ovarian neoplasms (67% vs 15%; P <.001), late stage disease (67% vs 40%; P =.008), and borderline cancer (67% vs 33%; P =.007).

CONCLUSION

Mass effect symptoms were the only symptoms that differentiated patients with early-stage ovarian cancer from all other groups of patients. However, one third of the patients with early ovarian cancer did not report any of these symptoms.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Massachusetts Medical Center, Worcester, MA, USA.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

15167861

Citation

Attanucci, Cara A., et al. "Differences in Symptoms Between Patients With Benign and Malignant Ovarian Neoplasms." American Journal of Obstetrics and Gynecology, vol. 190, no. 5, 2004, pp. 1435-7.
Attanucci CA, Ball HG, Zweizig SL, et al. Differences in symptoms between patients with benign and malignant ovarian neoplasms. Am J Obstet Gynecol. 2004;190(5):1435-7.
Attanucci, C. A., Ball, H. G., Zweizig, S. L., & Chen, A. H. (2004). Differences in symptoms between patients with benign and malignant ovarian neoplasms. American Journal of Obstetrics and Gynecology, 190(5), pp. 1435-7.
Attanucci CA, et al. Differences in Symptoms Between Patients With Benign and Malignant Ovarian Neoplasms. Am J Obstet Gynecol. 2004;190(5):1435-7. PubMed PMID: 15167861.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Differences in symptoms between patients with benign and malignant ovarian neoplasms. AU - Attanucci,Cara A, AU - Ball,Harrison G, AU - Zweizig,Susan L, AU - Chen,Annette H, PY - 2004/5/29/pubmed PY - 2004/7/10/medline PY - 2004/5/29/entrez SP - 1435 EP - 7 JF - American journal of obstetrics and gynecology JO - Am. J. Obstet. Gynecol. VL - 190 IS - 5 N2 - OBJECTIVE: The purpose of this study was to determine the symptoms that are experienced by patients who receive a diagnosis of early ovarian cancer and to compare those symptoms with the symptoms that are experienced by patients with late ovarian cancer, borderline ovarian cancer, and benign ovarian neoplasms. STUDY DESIGN: This study used a retrospective case-control design. Cases of invasive and borderline ovarian cancer (n=147 patients) were compared with 76 patients with benign ovarian neoplasms. RESULTS: Patients with early ovarian cancer were significantly more likely to have symptoms of mass effect (urinary frequency, constipation, palpable mass, pelvic pressure) compared with patients with benign ovarian neoplasms (67% vs 15%; P <.001), late stage disease (67% vs 40%; P =.008), and borderline cancer (67% vs 33%; P =.007). CONCLUSION: Mass effect symptoms were the only symptoms that differentiated patients with early-stage ovarian cancer from all other groups of patients. However, one third of the patients with early ovarian cancer did not report any of these symptoms. SN - 0002-9378 UR - https://www.unboundmedicine.com/medline/citation/15167861/Differences_in_symptoms_between_patients_with_benign_and_malignant_ovarian_neoplasms_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002937804001620 DB - PRIME DP - Unbound Medicine ER -